About CBOE

CBOE Rule Filings


Search: 
Year: 
  • Page
  • of 55
All Documents Filings Pending Filings Effective/Approved
Sort Documents By: 
Date Document Description Federal Register Publications
05/18/2012 SR-CBOE-2012-050  Proposal to Amend the Bylaws
05/18/2012 SR-CBOE-2012-049  Proposal to Adopt Silent Orders on CBSX
05/17/2012 SR-CBOE-2012-047  Proposal to Amend the Fees Schedule
05/17/2012 SR-CBOE-2012-048  Proposal Related to Distribution of Auction Messages
05/16/2012 SR-CBOE-2012-044 wi... Withdrawn
05/11/2012 SR-CBOE-2012-042  Proposal to List and Trade CBOE S&P 500 AM/PM Basis (SPBAS) Options
05/11/2012 SR-CBOE-2012-043  Proposes to Adopt Universal Spread Margin Rules
05/02/2012 SR-CBOE-2012-039  Proposal To Amend Registration and Qualification Requirements
04/30/2012 SR-CBOE-2012-041  Proposal to Amend the Fees Schedule
04/25/2012 SR-CBOE-2012-040  Proposal Related to FLEX Options
04/19/2012 SR-CBOE-2012-038  Proposal to Amend the Fees Schedule
04/11/2012 SR-CBOE-2012-013  Proposal to Adopt Self-Trade Prevention Orders on CBSX
04/10/2012 SR-CBOE-2012-037  Proposal to Amend the Fees Schedule
04/02/2012 SR-CBOE-2012-035  Proposal to Amend the Fees Schedule
04/02/2012 SR-CBOE-2012-036  Proposal to Amend the Fees Schedule
04/02/2012 SR-CBOE-2012-032 Wi... Withdrawn
04/02/2012 SR-CBOE-2012-034  Proposal to Correct Hyperlink in Rule 5.5A
03/30/2012 SR-CBOE-2012-033  Proposal Related to the FLEX Options
03/29/2012 SR-CBOE-2012-030  Proposal Related to the Fees Schedule
03/27/2012 SR-CBOE-2012-027  Proposal Related to FLEX Options
 
  • Page
  • of 55



Options involve risk and are not suitable for all investors. Prior to buying or selling an option, a person must receive a copy of Characteristics and Risks of Standardized Options (ODD). Copies of the ODD are available from your broker, by calling 1-888-OPTIONS, or from The Options Clearing Corporation, One North Wacker Drive, Suite 500, Chicago, Illinois 60606. The information on this website is provided solely for general education and information purposes and therefore should not be considered complete, precise, or current. Many of the matters discussed are subject to detailed rules, regulations, and statutory provisions which should be referred to for additional detail and are subject to changes that may not be reflected in the website information. No statement within the website should be construed as a recommendation to buy or sell a security or to provide investment advice. The inclusion of non-CBOE advertisements on the website should not be construed as an endorsement or an indication of the value of any product, service, or website. The Terms and Conditions govern use of this website and use of this website will be deemed acceptance of those Terms and Conditions.